P. 2. f. 003 Deep transcranial magnetic stimulation (TMS) for treatment resistant depression: a 22-week maintenance study Academic Article uri icon


  • Background: Major depressive disorder (MDD) is a common disorder that presents a clinical challenge in terms of both acute and long term treatment. Residual symptoms are common and lead to high relapse rates in the short term and disability in the longer term. Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a novel tool for the treatment of MDD. A large body of research suggests that rTMS has clinically meaningful antidepressive effects (George et al. 2010). Surprisingly, only limited data have been published that describe the possible role of rTMS in maintaining a therapeutic effect beyond an acute course of treatment for MDD. With the recognition that mood disorders are chronic relapsing illnesses, and in light of the high-standard continuation studies for ECT and pharmacological therapies, the

publication date

  • January 1, 2013